NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
19 hedge funds and large institutions have $1.23M invested in NKGen Biotech, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
71% less capital invested
Capital invested by funds: $4.24M → $1.23M (-$3.01M)
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$164K | |
| 2 | +$154K | |
| 3 | +$90.4K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$84.7K |
| 5 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
+$44.8K |
Top Sellers
| 1 | -$251K | |
| 2 | -$25.9K | |
| 3 | -$24K | |
| 4 |
BlackRock
New York
|
-$13.4K |
| 5 |
HF
HRT Financial
New York
|
-$950 |